Number of the records: 1
Development of Multidrug Resistance in Acute Myeloid Leukemia Is Associated with Alterations of the LPHN1/GAL-9/TIM-3 Signaling Pathway
Title Development of Multidrug Resistance in Acute Myeloid Leukemia Is Associated with Alterations of the LPHN1/GAL-9/TIM-3 Signaling Pathway Author Kočibálová Zuzana 1993- SCOPUS Co-authors Guzyová Martina 1989- Borovská Ivana 1993- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV ORCID Messingerová Lucia 1985- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV SCOPUS ORCID Copáková Lucia Sulová Zdena 1957- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV SCOPUS ORCID Breier Albert 1957- SCOPUS RID ORCID Source document Cancers. Vol. 13, no. 14 (2021), art. no. 3629 Language eng - English Country CH - Switzerland Document kind rozpis článkov z periodík (rbx) Citations BAILLY, Christian - THURU, Xavier - QUESNEL, Bruno. Modulation of the Gal-9/TIM-3 Immune Checkpoint with alpha-Lactose. Does Anomery of Lactose Matter? In CANCERS, 2021, vol. 13, no. 24, pp. Dostupné na: https://doi.org/10.3390/cancers13246365. JOSE LADERACH, Diego - COMPAGNO, Daniel. Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure. In CANCERS, 2021, vol. 13, no. 18, pp. Dostupné na: https://doi.org/10.3390/cancers13184529. SHI, Yuanwei - TANG, Danting - LI, Xiaoqi - XIE, Xiaoli - YE, Yufu - WANG, Lijuan. Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy? In FRONTIERS IN ONCOLOGY, 2022, vol. 12, no., pp. ISSN 2234-943X. Dostupné na: https://doi.org/10.3389/fonc.2022.889034. MAJERNIK, Martin - JENDZELOVSKY, Rastislav - VARGOVA, Jana - JENDZELOVSKA, Zuzana - FEDOROCKO, Peter. Multifunctional Nanoplatforms as a Novel Effective Approach in Photodynamic Therapy and Chemotherapy, to Overcome Multidrug Resistance in Cancer. In PHARMACEUTICS, 2022, vol. 14, no. 5, pp. Dostupné na: https://doi.org/10.3390/pharmaceutics14051075. PENG, X.H. - ZHU, X.F. - DI, T.N. - TANG, F.T. - GUO, X.J. - LIU, Y. - BAI, J. - LI, Y.H. - LI, L.J. - ZHANG, L.S. The yin-yang of immunity: Immune dysregulation in myelodysplastic syndrome with different risk stratification. In FRONTIERS IN IMMUNOLOGY. ISSN 1664-3224, SEP 23 2022, vol. 13. Dostupné na: https://doi.org/10.3389/fimmu.2022.994053. BAILLY, C. - THURU, X. - GOOSSENS, L. - GOOSSENS, J.F. Soluble TIM-3 as a biomarker of progression and therapeutic response in cancers and other of human diseases. In BIOCHEMICAL PHARMACOLOGY. ISSN 0006-2952, MAR 2023, vol. 209. Dostupné na: https://doi.org/10.1016/j.bcp.2023.115445. LV, Y. - MA, X. - MA, Y.X. - DU, Y.X. - FENG, J.F. A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9). In GENES & DISEASES. ISSN 2352-4820, NOV 2023, vol. 10, no. 6, p. 2366-2382. Dostupné na: https://doi.org/10.1016/j.gendis.2022.05.020. SHAO, Y. - GUI, X.R. - WANG, Y.X. - SHENG, L. - SUN, D. - ZENG, Q.D. - WANG, H.Y. Serum soluble immune checkpoint levels predict cervical lymph node metastasis of differentiated thyroid carcinoma patients. In CANCER MEDICINE. ISSN 2045-7634, SEP 2023, vol. 12, no. 17, p. 17648-17659. Dostupné na: https://doi.org/10.1002/cam4.6382. YILDIRIM, C. Galectin-9, a pro-survival factor inducing immunosuppression, leukemic cell transformation and expansion. In MOLECULAR BIOLOGY REPORTS. ISSN 0301-4851, DEC 2024, vol. 51, no. 1. Dostupné na: https://doi.org/10.1007/s11033-024-09563-w. Category ADMA - Scientific papers in foreign impacted journals registered in Web of Sciences or Scopus Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2021 Registered in WOS Registered in SCOPUS DOI 10.3390/cancers13143629 
article
File name Access Size Downloaded Type License Development of Multidrug Resistance in Acute Myeloid Leukemia Is Associated with Alterations of the LPHN1GAL-9TIM-3 Signaling Pathway.pdf available 3.2 MB 4 Publisher's version rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore N rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2021 2020 6.639 Q1 1.818 Q1
Number of the records: 1